GlassScriptPhysician profile
Scott Douglass Prater
NPI 1497951719
$4,259.11
in general payments reported to CMS, 2019-2025
11 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,458 · 2020: $1,380 · 2021: $187 · 2022: $112 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,485.08 | 2019-2025 | Indigo System |
| Stryker Corporation | $596.60 | 2019-2020 | |
| Rapid Medical LTD | $513.07 | 2020-2022 | |
| Medtronic USA, INC. | $293.99 | 2019-2020 | |
| Terumo Medical Corporation | $142.89 | 2019-2020 | |
| Depuy Synthes Sales INC. | $137.14 | 2020 | |
| Boston Scientific Corporation | $28.73 | 2019 | |
| Inari Medical, INC. | $24.47 | 2020 | |
| Sirtex Medical INC | $14.23 | 2020 | |
| B. Braun Interventional Systems INC. | $12.10 | 2019 | |
| Ekos Corporation | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Prater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.